Immunotherapy for Breast Cancer in India: Who Is Eligible, Options and Cost

Quick answer: Immunotherapy is not used for every breast cancer. Its best-established role is in triple-negative breast cancer (TNBC), usually given together with chemotherapy. For hormone-receptor-positive and HER2-positive breast cancer, endocrine therapy and HER2-targeted drugs remain the main treatments, and immunotherapy is generally studied rather than routine. Whether it is right for you depends on your cancer subtype, stage, biomarker results, earlier treatment and overall health.

If you or someone in your family has been told about immunotherapy for breast cancer, you probably have a lot of questions: Does it apply to my type? How is it given? What does it cost in India? This guide explains the options in plain language so you can have a more useful conversation with your oncologist.

Why the breast cancer subtype decides everything

“Breast cancer” is really several diseases. Doctors classify it using three markers: oestrogen receptor (ER), progesterone receptor (PR) and HER2. The combination decides the treatment plan.

  • Hormone-receptor-positive (ER/PR positive): usually treated with hormone (endocrine) therapy, often with newer targeted tablets. Immunotherapy is not a standard option.
  • HER2-positive: treated with HER2-targeted medicines. Immunotherapy is not standard.
  • Triple-negative (ER, PR and HER2 all negative): has fewer targeted options, which is why immunotherapy research has focused here.

Immunotherapy options used in breast cancer

Checkpoint inhibitors (for triple-negative disease)

Checkpoint inhibitors such as pembrolizumab release the “brakes” that cancer uses to hide from the immune system. In clinical trials, pembrolizumab combined with chemotherapy has been used for high-risk early-stage TNBC (given before surgery and continued afterwards) and for advanced TNBC whose tumours show a high PD-L1 score. Which of these uses is approved and available in India depends on the drug’s current CDSCO label, so your oncologist will confirm what applies to you. You can read more in our guide to checkpoint inhibitors approved in India.

Personalised cell-based immunotherapy

Dendritic cell therapy uses a patient’s own immune cells, trained in the laboratory to recognise features of the tumour. At Denvax, it is offered as part of an individual treatment plan alongside or after standard care, not as a replacement for surgery, chemotherapy or radiotherapy. The evidence in breast cancer is still developing, and your doctor will explain honestly what is and is not known. For the basics, see our patient guide to dendritic cell therapy.

Who may be considered for immunotherapy?

Doctors usually look at the following before recommending immunotherapy:

  • Confirmed breast cancer subtype, especially triple-negative status
  • Stage of disease and whether surgery has been done
  • PD-L1 testing result, where relevant to the drug being considered
  • Previous treatments and how the cancer responded
  • Overall health, including liver, kidney, thyroid and any autoimmune conditions

Pathology and biomarker tests are done at your hospital or laboratory. Denvax does not perform diagnostic testing, so bring your biopsy report, receptor status and scan reports to the consultation. Our article on immunotherapy eligibility explains the checklist in more detail.

Side effects to know about

Immunotherapy side effects differ from chemotherapy. Because the immune system is activated, it can sometimes inflame healthy organs. Reported effects include tiredness, skin rash, diarrhoea, thyroid problems and, less commonly, inflammation of the lungs, liver or other organs. Most can be managed when caught early, which is why you should report new symptoms to your care team promptly. Our guide on signs immunotherapy is working also covers what to watch for.

What does breast cancer immunotherapy cost in India?

There is no single price. The total depends on:

  • The medicine used (branded or biosimilar, where available) and the dose
  • The number of cycles your oncologist plans
  • Combination chemotherapy and supportive medicines
  • Hospital or day-care charges and monitoring tests

For a worked example of how drug costs add up, see Keytruda (pembrolizumab) price in India, and for breast cancer costs by stage, see our breast cancer treatment cost guide. If cost is a concern, our page on financial assistance for cancer treatment lists support options.

How to get a second opinion at Denvax

Our oncologists review your reports, explain which options fit your subtype and stage, and tell you plainly when immunotherapy is unlikely to help. Not sure what to expect? Read what happens at your first Denvax consultation. Denvax Cancer Center is at 18 Poorvi Marg, Vasant Vihar, New Delhi, a short walk from Vasant Vihar Metro.

Frequently asked questions

Does immunotherapy work for all types of breast cancer?

No. Its clearest role is in triple-negative breast cancer. For other subtypes, hormone therapy and HER2-targeted treatment remain the main options, and immunotherapy is mostly in clinical research.

Is immunotherapy used instead of chemotherapy for breast cancer?

In triple-negative breast cancer, checkpoint inhibitors are generally given together with chemotherapy rather than in place of it. Your oncologist decides the combination.

What tests are needed before immunotherapy?

Typically the biopsy report with ER, PR and HER2 status, a PD-L1 result where relevant, recent scans and blood tests for organ function and thyroid. These are done at your hospital or lab.

Can immunotherapy cure breast cancer?

No treatment can promise a cure. Immunotherapy aims to improve disease control and, in some patients, long-term outcomes. Results vary from person to person.

How long does immunotherapy treatment last?

It depends on the drug and the stage. Some plans run for several months alongside chemotherapy, others continue for longer, with regular scans to review response.

Talk to a Denvax oncologist: book a consultation to review your reports and get a plan tailored to your breast cancer subtype. निःशुल्क परामर्श के लिए हमसे संपर्क करें।

Medical review: [Reviewer name and qualifications to be added before publishing]. This article is for information and does not replace advice from your oncologist. Results may vary. Consult your oncologist.

Denvax Clinic

Denvax Clinic

You May Also Like

Denvax Clinic: India’s Leading Cancer Centre for Immunotherapy